1. Home
  2. PASW vs DRMA Comparison

PASW vs DRMA Comparison

Compare PASW & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASW

Ping An Biomedical Co. Ltd. Ordinary Shares

N/A

Current Price

$0.14

Market Cap

3.7M

ML Signal

N/A

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

N/A

Current Price

$1.27

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PASW
DRMA
Founded
2021
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
4.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PASW
DRMA
Price
$0.14
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
629.3K
1.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.59
52 Week High
$1.08
$7.33

Technical Indicators

Market Signals
Indicator
PASW
DRMA
Relative Strength Index (RSI) 35.97 43.34
Support Level $0.14 $1.11
Resistance Level $0.24 $2.29
Average True Range (ATR) 0.02 0.08
MACD 0.00 0.04
Stochastic Oscillator 24.71 70.83

Price Performance

Historical Comparison
PASW
DRMA

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Share on Social Networks: